Novel genetic subgroups of FL are characterized by distinct biological features. (A) Expression of CREBBP, FOXP1, and MYC across tumors in de novo DLBCL and within FL cases in each subgroup. (B) Mutational signatures SBS1, SBS5, and SBS9, but not SBS8, are differentially enriched between cFL and dFL tumors.